Ph.D., Senior Director, Molecular Biology & Sequencing, Foundation Medicine
Geoff is currently leading the lab responsible for the research, development and optimization of clinically validated, targeted next-generation DNA and RNA sequencing assays to enable comprehensive genomic profiling of conventional formalin fixed, paraffin-embedded (FFPE) tissues and liquid biopsy samples from patients with cancer. Prior to joining Foundation, Geoff worked for Pacific Biosciences developing a single-molecule DNA sequencing system. Geoff received a BA degree from Cornell University in Cell Biology and a Ph.D. at Stanford University in Microbiology and Immunology where he researched the regulation of translation initiation by the Hepatitis C Virus IRES.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Liquid biopsies have the potential to bring precision medicine into the care of cancer patients for whom access to tissue is challenging. However, detecting tumor-specific DNA variants in blood samples presents challenges to the analytical validity and operational efficiency of these tests. This session will explore how leaders in the field are addressing these challenges to bring liquid biopsy to clinicians and their patients.